GlassScriptPhysician profile
Tamara L Moreland
NPI 1912051251
$1,619.38
in general payments reported to CMS, 2019-2025
27 companies · $389 in 2025
The $389 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $365 · 2022: $251 · 2023: $284 · 2024: $330 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,003.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $302.00 | 2021-2025 | |
| Novo Nordisk INC | $293.01 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $92.88 | 2022-2025 | Farxiga, Airsupra |
| Abbott Laboratories | $87.00 | 2021-2025 | Freestyle Libre 3 |
| E.R. Squibb & Sons, L.L.C. | $75.18 | 2021 | |
| Glaxosmithkline, LLC. | $68.05 | 2023-2025 | Trelegy Ellipta |
| Cranial Technologies, INC | $66.70 | 2023-2025 | Doc Band |
| Takeda Pharmaceuticals U.S.A., INC. | $60.99 | 2021-2022 | |
| Exact Sciences Corporation | $56.95 | 2023-2024 | Cologuard Collection Kit |
| Inspire Medical Systems, INC. | $54.05 | 2025 | Inspire |
| Astellas Pharma US INC | $52.99 | 2024 | Veozah |
| Pfizer INC. | $50.15 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.23 | 2021-2024 | Jardiance |
| Lilly USA, LLC | $39.13 | 2023-2024 | Jardiance |
| Sage Therapeutics, LLC | $35.89 | 2025 | Zurzuvae |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $33.15 | 2022-2023 | Qelbree |
| Merck Sharp & Dohme LLC | $29.96 | 2021-2022 | |
| Tms Neurohealth Centers INC. | $27.16 | 2025 | Tms Neurohealth Centers INC. |
| Jazz Pharmaceuticals INC. | $20.82 | 2021 | |
| Almatica Pharma LLC | $20.78 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $20.44 | 2022 | |
| Allergan, INC. | $17.68 | 2021 | |
| Idorsia Pharmaceuticals US INC | $17.05 | 2023 | Quviviq |
| Medtronic, INC. | $16.78 | 2025 | Inceptiv |
| Aerin Medical INC. | $15.63 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.58 | 2022 | |
| Amgen INC. | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Moreland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.